The catecholaminergic–cholinergic balance hypothesis of bipolar disorder revisited

2014/08/05 by Jordy van Enkhuizen, David S. Janowsky, Berend Olivier +4 · 103 citations
Medicine · Neuroscience · Psychology · #Balance (ability) #Bipolar Disorder and Treatment #Catecholaminergic #Cholinergic #Dopamine #Neuroscience #Neurotransmitter Receptor Influence on Behavior #Psychology #Treatment of Major Depression

paper · open access · doi:10.1016/j.ejphar.2014.05.063

published in European Journal of Pharmacology 753, 114-126 (Elsevier BV)

openalex publication_date 2014/08/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• The emerging neuroimmune hypothesis of bipolar disorder: An updated overview of neuroimmune and microglial findings
• Investigating the mechanism(s) underlying switching between states in bipolar disorder
• Rodent models of treatment-resistant depression. [europepmc]
• Investigating the mechanism(s) underlying switching between states in bipolar disorder. [europepmc]
• Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. [europepmc]
• Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies. [europepmc]
• Amphetamine increases activity but not exploration in humans and mice. [europepmc]
• Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression. [europepmc]
• 1 H-NMR, 1 H-NMR T 2 -edited, and 2D-NMR in bipolar disorder metabolic profiling. [europepmc]
• Is Mania the Hypertension of the Mood? Discussion of A Hypothesis. [europepmc]
• Circuits Regulating Pleasure and Happiness in Bipolar Disorder. [europepmc]
• Animal models for bipolar disorder: from bedside to the cage. [europepmc]
• A neuronal mechanism underlying decision-making deficits during hyperdopaminergic states. [europepmc]
• Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder. [europepmc]
• Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics. [europepmc]
• Metabolomics Analyses of 14 Classical Neurotransmitters by GC-TOF with LC-MS Illustrates Secretion of 9 Cell-Cell Signaling Molecules from Sympathoadrenal Chromaffin Cells in the Presence of Lithium. [europepmc]
• Integrative Transcriptomics Reveals Sexually Dimorphic Control of the Cholinergic/Neurokine Interface in Schizophrenia and Bipolar Disorder. [europepmc]
• The role of acetylcholine in negative encoding bias: Too much of a good thing? [europepmc]
• The catecholaminergic neurotransmitter system in methylmercury-induced neurotoxicity. [europepmc]
• Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia. [europepmc]
• Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias. [europepmc]
• Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis. [europepmc]
• Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex. [europepmc]
• Microstructural imaging and transcriptomics of the basal forebrain in first-episode psychosis. [europepmc]
• Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity. [europepmc]
• Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities. [europepmc]
• Septohippocampal cholinergic system at the intersection of stress and cognition: Current trends and translational implications. [europepmc]